Skip to main content

GOLDMAN SACHS GROUP INC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY

Position in RYTM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$236,105,516
+$65,171,896 QoQ
Shares Held
2,126,502
+8.2% QoQ
Ownership
3.09%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#12
of 299 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. RYTM ranks #9 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RYTM

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $236,105,516 2,126,502
2026-03-31 $170,933,620 1,965,432
2025-12-31 $195,975,896 1,830,866
2025-09-30 $191,241,026 1,893,663
2025-06-30 $109,553,892 1,733,722
2025-03-31 $86,759,986 1,637,908
2024-12-31 $101,447,291 1,812,206
2024-09-30 $203,262,511 3,879,796
2024-06-30 $217,151,352 5,288,635
2024-03-31 $221,485,671 5,111,601
2023-12-31 $232,053,525 5,047,934
2023-09-30 $118,305,402 5,160,541
2023-06-30 $85,517,353 5,186,013
2023-03-31 $94,742,940 5,310,703
2022-12-31 $151,476,182 5,201,792
2022-09-30 $117,040,860 4,777,178
2022-06-30 $13,115,601 3,160,386
2022-03-31 $38,473,919 3,339,750
2021-12-31 $30,903,548 3,096,548
2021-09-30 $37,943,465 2,905,319
2021-06-30 $20,915,571 1,068,211
2021-03-31 $14,020,204 659,154
2020-12-31 $1,558,208 52,412
2020-09-30 $1,219,327 56,268
2020-06-30 $737,527 33,073
2020-03-31 $790,131 51,914